Pilot launch complete: GlaxoSmithKline’s malaria shot scores WHO backing for wider rollout in Africa esagonowsky Wed, 10/06/2021 – 14:14 More: Pilot launch complete: GlaxoSmithKline's malaria shot scores WHO backing for wider rollout in Africa Source: fierce
read moreBiogen, mRNA players on Merck’s M&A radar as CEO still hungry for deals after $11.5B Acceleron buy: FT aliu Wed, 10/06/2021 – 11:31 More: Biogen, mRNA players on Merck's M&A radar as CEO still hungry for deals after .5B Acceleron
read moreBuyers clamor for Merck’s COVID-19 antiviral molnupiravir, but pricing is already controversial kdunleavy Wed, 10/06/2021 – 10:23 More: Buyers clamor for Merck's COVID-19 antiviral molnupiravir, but pricing is already controversial Source: fierce
read moreWith D.C. drug pricing talks up in the air, the ‘endgame’ could still ‘have a bite,’ analyst says esagonowsky Wed, 10/06/2021 – 09:58 More: With D.C. drug pricing talks up in the air, the 'endgame' could still 'have a bite,'
read moreNICE backs Novartis’ Adakveo via special channel despite ‘high uncertainty’ about cost, long-term efficacy aliu Wed, 10/06/2021 – 09:23 More: NICE backs Novartis' Adakveo via special channel despite 'high uncertainty' about cost, long-term efficacy Source: fierce
read moreUK-based Scancell Holdings has announced that its first subject has been dosed in its COVIDITY clinical trial in South Africa. More: First subject given COVID-19 vaccine candidate in UK-based Scancell’s COVIDITY trial Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals